Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 27, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.
Journal: Journal for immunotherapy of cancer
Published: April 15, 2026
Identity among adolescent and young adult cancer survivors: an exploratory qualitative study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 18, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 10, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.
Journal: Cancer research communications
Published: June 25, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma.
Journal: Journal for immunotherapy of cancer
Published: May 28, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma.
Journal: ESMO open
Published: May 21, 2025
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 14, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 16, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.
Journal: JCO oncology advances
Published: November 06, 2024
Last Updated: 09/26/2026